RBC Bearings Total Cost of Revenue increased by 12.0% to $288.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.9%, from $244.30M to $288.00M. Over 4 years (FY 2022 to FY 2026), Total Cost of Revenue shows an upward trend with a 15.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $92.43M | $98.44M | $173.61M | $221.32M | $212.90M | $218.10M | $205.60M | $227.90M | $219.20M | $219.30M | $215.90M | $235.40M | $222.30M | $224.10M | $219.50M | $244.30M | $240.80M | $254.70M | $257.20M | $288.00M |
| QoQ Change | — | +6.5% | +76.4% | +27.5% | -3.8% | +2.4% | -5.7% | +10.8% | -3.8% | +0.0% | -1.6% | +9.0% | -5.6% | +0.8% | -2.1% | +11.3% | -1.4% | +5.8% | +1.0% | +12.0% |
| YoY Change | — | — | — | — | +130.3% | +121.6% | +18.4% | +3.0% | +3.0% | +0.6% | +5.0% | +3.3% | +1.4% | +2.2% | +1.7% | +3.8% | +8.3% | +13.7% | +17.2% | +17.9% |
| Segment | Q4 '26 |
|---|---|
| Industrial | $158.30M |
| Aerospace Defense | $129.70M |
| Total | $288.00M |